NEWS Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer - 06/5/2010 Poniard Pharmaceuticals Announces Results of Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer to Be Presented at the American Society of Clinical Oncology 2010 Annual Meeting - 05/10/2010 Poniard Pharmaceuticals Reports First Quarter 2010 Financial Results - 05/10/2010
EVENTS & PRESENTATIONS
Q1 2010 Poniard Pharmaceuticals Earnings Conference Call Monday, May 10, 2010 4:30 p.m. ET